Latest PEG ratio for Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War): -1.58 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-1.58
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) (ORIAU) currently reports a PEG ratio of -1.58. That is below the sector sector average of 6.34. Use the charts on this page to explore Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s PEG ratio history and peer comparisons.
Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s PEG ratio of -1.58 is lower than the its sector sector average of 6.34. That is roughly 125.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s market price to a fundamental measure such as earnings, sales, or book value. At -1.58, ORIAU can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -1.58, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 6.34. From there, open related valuation or income-statement pages for Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War), and consider following ORIAU for alerts when major investors trade the stock.